Active Substance & Generic Molecule Directory
Trastuzumab in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Trastuzumab registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
11
Registered Brands
Availability in Malaysia:11 Prescription (MAL-A)
Showing 11 of 11 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL15125069ARZ | HERCEPTIN 600MG/5ML SOLUTION FOR INJECTION | 600mg 1vial | Prescription (MAL-A) | ROCHE (MALAYSIA) SDN. BHD. | Compare → |
| MAL20081813ARSZ | HERCEPTIN VIAL 150 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION | 150MG | Prescription (MAL-A) | ROCHE (MALAYSIA) SDN. BHD. | Compare → |
| MAL20014475ARZ | HERCEPTIN VIAL 440MG POWDER FOR CONCENTRATE | 440.0MG | Prescription (MAL-A) | ROCHE (MALAYSIA) SDN. BHD. | Compare → |
| MAL15095035ARSZ | HERCEPTIN VIAL 440MG POWDER FOR CONCENTRATE | 440mg | Prescription (MAL-A) | ROCHE (MALAYSIA) SDN. BHD. | Compare → |
| MAL19056037AZ | Herzuma (trastuzumab) 150 mg Powder for Concentrate for Solution for Infusion | 150 mg | Prescription (MAL-A) | CELLTRION HEALTHCARE MALAYSIA SDN. BHD. | Compare → |
| MAL19056038AZ | Herzuma (trastuzumab) 440 mg Powder for Concentrate for Solution for Infusion | 440 mg | Prescription (MAL-A) | CELLTRION HEALTHCARE MALAYSIA SDN. BHD. | Compare → |
| MAL25096009AZ | Ogivri Trastuzumab (rDNA Origin) Powder for concentrate for solution for infusion 420mg/vial | 420 mg | Prescription (MAL-A) | BIOCON SDN BHD | Compare → |
| MAL22056048ARZ | PHESGO Solution for Subcutaneous Injection 1200mg/600mg/15mL | 600 mg | Prescription (MAL-A) | ROCHE (MALAYSIA) SDN. BHD. | Compare → |
| MAL22056047ARZ | PHESGO Solution for Subcutaneous Injection 600mg/600mg/10mL | 600 mg | Prescription (MAL-A) | ROCHE (MALAYSIA) SDN. BHD. | Compare → |
| MAL18126013AZ | ZUHERA Trastuzumab for Injection (rDNA Origin) 150mg/vial | 150 mg | Prescription (MAL-A) | BIOCON SDN BHD | Compare → |
| MAL18126014AZ | ZUHERA Trastuzumab for Injection (rDNA Origin) 440 mg/vial | 440 mg | Prescription (MAL-A) | BIOCON SDN BHD | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.